MedLife purchases the full block of shares of OncoCard Brasov Hospital – Business Review

Founded in 2012, OncoCard is one of the most modern oncologic hospitals in Romania, based on an innovative concept of Integrative Medicine which starts during the diagnosis stage of the patient and covers the whole specific active treatment period. The institution includes ambulatory care, an oncological surgery unit, departments for hematology, radiotherapy, and medical imaging, and also its own medical lab used for admitted patients. Since opening, OncoCard Brasov received EUR 24 million worth of investments, the hospital recording a turnover of LEI 41.8 million in 2018.

This partnership comes from our strategy to expand and develop the oncologic sector and we are glad to have such a great team of experts besides us, which will strengthen the medical excellency zone even further. OncoCard comes to complete the oncologic services provided by us in the surgery units of all MedLife hospitals, and will become the first integrated oncologic centre in Brasov, and the second in our group, after Sibiu. For us, its an area of interest and we dont rule out consistent investments over the next few years in oncologic treatment of excellence on a national level. Declared Mihai Marcu, President and CEO of MedLife.

The transaction will be analyzed by the Romanian Competition Council, and once approved could become the most important piece of business for the MedLife group in 2019.

We have always advocated for excellency in healthcare, imposing on ourselves to become a landmark of quality for the level of medical services offered, managing to instill trust and courage in our patients. Said Raluca Buzea, OncoCard Brasov shareholder.

By taking over OncoCard Brasov, MedLife group have reached a portfolio of 27 successful acquisitions, the most recently announced one being that of Micromedica Medical Centre.

Photo: OncoCard.ro

See the rest here:
MedLife purchases the full block of shares of OncoCard Brasov Hospital - Business Review